Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-24-005760
Filing Date
2024-09-16
Accepted
2024-09-16 17:20:25
Documents
1
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A bglc_def14a.htm DEF 14A 548811
  Complete submission text file 0001477932-24-005760.txt   550078
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41750 | Film No.: 241301947
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)